This week$Hang Seng Index (800000.HK)$It closed at 17325.66 points, up 7.21% during the week.
This week, there are a total of 3 new shares on the main board of Hong Kong stocks, one new share has been announced, three new shares have been listed, and no new shares have been sold.
Three new shares listed this week$MANY IDEA CLOUD (06696.HK)$、$ZIBUYU (02420.HK)$及$SCIENTECH (02291.HK)$All of them stand out in the dark disk of Fortune. I think Yun closed up 83.67% in the dark market of Fortune, earning HK $3280 per hand, and closing up 2.04% on the first day of listing. Zi Bu closed up 8.4% in the dark market and 5.47% on the first day of listing.
Hot US stock IPO, the first stock of China's new accommodation economy.$Atour Lifestyle Holdings (ATAT.US)$Officially landed on NASDAQ on November 11, US Eastern time. The first day of trading rose as much as 55%, closing up 17.09% at $12.88, with a total market capitalization of $1.68 billion.
Ying NuoweiIt is a leading provider of integrated solutions for non-vascular interventional surgery in China, with operations all over the world. According to the information of cauterization Consulting, the company is one of the few companies in the world that can provide integrated solutions for major medical specialties in non-vascular interventional surgery, including urology, gastroenterology, hepatobiliary surgery, respiratory, thoracic surgery, otorhinolaryngology, gynaecology and general surgery. The company has developed the most comprehensive product portfolio of medical devices for non-vascular interventional surgery in urology in the world and China.
To date, the company has 33 products approved in China, the United States, the European Union and / or Japan; according to CIC, the company has the most comprehensive portfolio of disposable endoscopes in China to provide services for all medical specialties that mainly perform non-vascular interventional surgery, including nine products that have been approved in China, the United States, the European Union and ╱ or Japan and five products that are under application.
Since its establishment, Invid has received investment from Nano Venture Capital, Temasek, Boyuan Capital, Hillhouse, Chunyuan Capital, Taikang Life Insurance, Wei Haochuangxin, Xianli Investment, Xingzheng Capital, Zhangjiang Hi-Tech, Trivest and other institutions. Before IPO, Nano Ventures held a 10.0 per cent stake in Invid through Ningbo Yonglian, making it the largest institutional investor, while Temasek, Boyuan Capital and Hillhouse held 4.2 per cent, 4.2 per cent and 3.6 per cent respectively.
Mace HealthOperate one of the largest online professional physician platforms in China (based on registered physician users and average monthly active users in 2021, according to Frost Sullivan). On December 31, 2021, the company's platform had about 2.6 million registered physician users, and the company's average monthly active users reached about 2.5 million in 2021. The registered physician users and the average number of monthly active users of the company's platform are in the leading position in China's online physician platform. The company's Mace Medical platform also has a high proportion of deputy chief physicians and senior doctors with professional titles above.
On December 31, 2020, according to the data of the National Health Commission, the total number of registered physician users with deputy chief physician and above titles on the company's Mace medical platform accounted for 68.8% of the total number of doctors with deputy chief physician and above titles in China.
Shenghui cleaningIt is a comprehensive environmental cleaning and maintenance service provider in China and one of the well-known property cleaning service providers in Guangdong Province. With more than 20 years of industry experience and advantages based in Guangdong Province, since its establishment in 2000, the company has steadily developed its business to provide a wide range of services to more than 700 customers and expanded its coverage to 14 provincial regions in China.
The company's main clients during the track record period include Fortune Global 500 Chinese real estate developers, Fortune Global 500 real estate consulting companies, major real estate developers and property management companies in Asia and China, government departments and border control stations in Guangdong Province and Chinese airport management companies.
Hard work resourcesIs a leading company in the trading and production of nickel products. In the field of nickel product trade, the company's nickel product trade volume ranked first in the world in 2021. According to the cautionary report, the company's nickel ore trade volume ranked first in China in 2019, 2020 and 2021, with a market share of 26.8% in 2021.
In terms of nickel products, the HPAL project developed by the company with Indonesian partners in Obi Island, Indonesia is one of the most technologically advanced wet smelting projects for nickel-cobalt compounds in the world and the lowest cash cost nickel-cobalt compound production project in the world. The company's HPAL project ranks first among all projects using HPAL process that have been put into production or under construction in the world, with a market share of 17.1%. As of the last practical date, annual design capacity (total of all three phases) ranks first among all projects using HPAL process that have been put into production or under construction in Indonesia. The market share is 34.3%.
This week, there are three new shares listed, namely, Zibuyu, Duoxianyun and Xintai Medical, all of which have performed well in the dark market of Futu.
China's leading one-stop smart marketing technology platform$MANY IDEA CLOUD (06696.HK)$In the dark market of Futu, it closed up 83.67%, earning HK $3280 per hand. The first day of listing maintained a good momentum, closing up 2.04%. It closed up 83.67%, 8.4% and 2.23% respectively in the dark market, while Zibuyu closed up 5.47% at HK $8.29 on the first day of listing.
One of the largest cross-border e-commerce companies in China$ZIBUYU (02420.HK)$It closed up 8.4% in the dark market and 5.47% at HK $8.29 on the first day of listing.
